Rb Gene product, Human, Monoclonal Antibody : Trial Size
Code No: MK-15-1S
Datasheet:
FID:5699 | PATH:sites/default/files/datasheets/MK-15-1S.PDF
Background:
Mutation of the retinoblastoma tumor suppressor gene alone is sufficient to cause retinoblastoma in humans, suggesting that it might play a role in the normal coordination of cell proliferation and cell death. Deletion or mutational inactivation of the retinoblastoma tumor suppressor protein (Rb) is correlated with the genesis of a variety of human cancers including retinoblastoma, osteosarcoma, and carcinomas of the breast, bladder, and lung. Rb protein is phosphorylated by cyclinD-Cdk4/Cdk6 and cyclinA/cyclinE-Cdk2 during the G1/S transition. This phosphorylation causes the inactivation of the growth inhibitory functions of Rb. Rb undergo phosphorylation and attendant functional inactivation, the cell proceed into late G1.
Product Type:
Primary Antibody
Species Reactivities:
Human
Related Products:
17-3 Anti-Cyclin D1 (5D4)
K0062-3S Anti-Cyclin D1 (DCS-6)
K0063-3 Anti-Cyclin D2 (DCS-3)
K0064-3S Anti-Cyclin D2 (DCS-5)
K0013-3S Anti-Cyclin D3 (DCS-22)
MT-19-3S Anti-Cdc2Hs (5F6)
K0069-3S Anti-CDC6 (DCS-180)
K0070-3S Anti-CDC7 (DCS-342)
K0071-3S Anti-CDC25A (DCS-120)
K0072-3S Anti-CDC25A (DCS-121)
K0073-3S Anti-CDC25A (DCS-124)
MK-13-3S Anti-Cdk2 (8A12)
K0065-3S Anti-Cdk4 (DCS-156)
K0066-3S Anti-Cdk6 (DCS-83)
K0067-3 Anti-Cdk6 (DCS-130) available soon
K0068-3S Anti-Cdk7 (DCS-MO1)
K0077-3S Anti-p16INK4a (DCS-50)
K0078-3 Anti-p15INK4b (DCS-114) available soon
K0079-3S Anti-p18INK4c (DCS-118)
K0080-3S Anti-p19INK4d (DCS-100)
K0081-3S Anti-p21WAF1/CIPP1 (DCS-60)
K0082-3S Anti-p27KIPP1 (DCS-72)
K0084-3S Anti-p14ARF (DCS-240)
K0085-3S Anti-Cdh1 (DCS-266)
K0087-3S Anti-Chk2 (DCS-270)
K0088-3S Anti-Chk2 (DCS-273)
K0094-3S Anti-E2F-4 (TFE42)
K0095-3S Anti-DP-1 (TFD10)
M069-3S Anti-Mcm2 (4B8)
M038-3S Anti-Mcm3 (3A2)
M049-3S Anti-Mcm7 (4B4)
M045-3S Anti-phospho RB (2C4)
K0091-3S Anti-RB2 (DCS-211)
References:
1) Lalande, M., et al. Cancer Genet.Cytogenet. 13,
283-295 (1984)
2) Lee, W. H., et al. Science, 235, 1394-1399 (1987)
3) Taya, Y., et al. Biochem. Biophys. Res. Commun. 164,
580-586 (1989)
4) Lin, B. T. Y., et al. EMBO J. 10, 857-864 (1991)
5) Wang, N.P., et al. Cell Growth Differ. 1, 233-239 (1990)
Formulation:
10 g IgG in 100 L volume of PBS containing 0.1% Sodium azide as preservative.Sodium azide has been reported to form potentially explosive lead or copper azide in plumbing. To prevent forming of these compounds, flush drains enough after disposing of solutions containing sodium azide.
Reactivity:
This antibody reacts with human retinoblastoma gene product (110-115 kDa).
Intended Use:
For Research use only. Not for use in diagnostic procedure.
|